MC Liu

1.3k citations
32 papers · 735 · h-index 13

Impact in

  • Hematology top 2%
    • Acute Myeloid Leukemia Research
  • Genetics top 5%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Co-authors
Ming Yao (6 shared papers)S-J Wu (5 shared papers)M-H Tseng (5 shared papers)C-Y Chen (5 shared papers)C-W Liu (5 shared papers)Woei Tsay (6 shared papers)Bor‐Sheng Ko (5 shared papers)Yee‐Chun Chen (6 shared papers)
Journals
Cancer Research (15 papers)Leukemia (3 papers)Blood Cancer Journal (2 papers)Annals of Oncology (1 paper)British Journal of Cancer (1 paper)
Partner nations
TaiwanUnited StatesUnited Kingdom

In The Last Decade

MC Liu

31 papers receiving 725 citations

Peers

MC Liu
Comparison fields: 5 of 59
  • Hematology 426
  • Genetics 158
  • Cancer Research 164
  • Oncology 167
  • Otorhinolaryngology 17
Replace N. Bekele with:
N. Bekele United States
Heinz-A. Horst Germany
Prapti A. Patel United States
M Vanrumbeke France
R B Arlinghaus United States
Sujiang Zhang China
M Lübbert Germany
Vera Magistroni Italy
François G. Kavelaars Netherlands
Rhonda E. Ries United States
MC Liu relative to N. Bekele United States N. Bekele's profile →
Citations per field
00.5×2×3×4.3×
N. Bekele · 1×
Citations per year

Countries citing papers authored by MC Liu

Since Specialization
Citations

This map shows the geographic impact of MC Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MC Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MC Liu more than expected).

Fields of papers citing papers by MC Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MC Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MC Liu. The network helps show where MC Liu may publish in the future.

Co-authors

The 25 scholars most cited alongside MC Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with MC Liu Line = papers co-authored together MC Liu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
Leukemia ·(unknown), W-C Lei, Bor‐Sheng Ko, (unknown), C-Y Chen, (unknown), Ming Yao, Woei Tsay, S-J Wu, (unknown), (unknown), Yee‐Chun Chen, (unknown), (unknown), Lee Fy, MC Liu, C-W Liu, M-H Tseng, (unknown), (unknown)
2010128
2
TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution
Blood Cancer Journal ·(unknown), (unknown), (unknown), (unknown), Liang‐In Lin, M-H Tseng, (unknown), MC Liu, C-W Liu, (unknown), Ming Yao, Chi‐Chung Li, (unknown), Bor‐Sheng Ko, (unknown), C-Y Chen, (unknown), S-J Wu, Woei Tsay, Yee‐Chun Chen, (unknown)
2015111
3
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
Leukemia ·Cheng‐Hong Tsai, (unknown), (unknown), (unknown), (unknown), (unknown), M-H Tseng, (unknown), (unknown), MC Liu, C-W Liu, Liang‐In Lin, Woei Tsay, Ming Yao, Chi‐Chung Li, (unknown), Bor‐Sheng Ko, (unknown), C-Y Chen, (unknown), S-J Wu, (unknown)
201685
4
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
Leukemia ·(unknown), (unknown), (unknown), (unknown), C-Y Chen, (unknown), Y-J Lai, M-H Tseng, (unknown), (unknown), Lee Fy, (unknown), MC Lee, MC Liu, C-W Liu, Liang‐In Lin, Ming Yao, (unknown), Bor‐Sheng Ko, (unknown), S-J Wu, Woei Tsay, Yee‐Chun Chen, (unknown)
201370
5
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome
Blood Cancer Journal ·T-C Chen, (unknown), (unknown), (unknown), (unknown), C-Y Chen, M-H Tseng, (unknown), Y-J Lai, (unknown), Lee Fy, MC Liu, C-W Liu, (unknown), Ming Yao, (unknown), Bor‐Sheng Ko, (unknown), S-J Wu, Woei Tsay, Yee‐Chun Chen, (unknown)
201463
6
Abstract S3-2: Neoadjuvant Pertuzumab (P) and Trastuzumab (H): Antitumor and Safety Analysis of a Randomized Phase II Study ('NeoSphere')
Cancer Research ·Luca Gianni, Tadeusz Pieńkowski, Y-H Im, L Roman, L-M Tseng, MC Liu, A. Lluch-Hernández, Semiglazov Vf, Tania Szado, G. Ross
201049
7
S5-1: Neoadjuvant Pertuzumab (P) and Trastuzumab (H): Biomarker Analyses of a 4-Arm Randomized Phase II Study (NeoSphere) in Patients (pts) with HER2−Positive Breast Cancer (BC).
Cancer Research ·Luca Gianni, Giampaolo Bianchini, Astrid Kiermaier, Giulia Bianchi, Y-H Im, Tadeusz Pieńkowski, L Roman, MC Liu, L-M Tseng, Jithendra Ratnayake, Tania Szado, G. Ross, Pinuccia Valagussa
201133
8
Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia
British Journal of Cancer ·(unknown), (unknown), Liu Cy, Lee Mc, (unknown), Chen Cy, (unknown), Huang Cf, Lee Fy, MC Liu, Ming Yao, (unknown)
201130
9
Characterization of Philadelphia-chromosome-positive acute leukemia by clinical, immunocytochemical, and gene analysis.
PubMed ·Hwei‐Fang Tien, Chenghui Wang, SM Chuang, Lee Fy, MC Liu, Yee‐Chun Chen, Shen Mc, Dong‐Tsamn Lin, Kai‐Hsin Lin, Lin Ks
199223
10
Abstract PD6-10: KEYNOTE-086 cohort B: Pembrolizumab monotherapy for PD-L1–positive, previously untreated, metastatic triple-negative breast cancer (mTNBC)
Cancer Research ·Sylvia Adams, Sherene Loi, D. Toppmeyer, DW Cescon, Michelino De Laurentiis, Rita Nanda, EP Winer, Hirofumi Mukai, Kenji Tamura, AC Armstrong, MC Liu, Hiroji Iwata, L Ryvo, Pauline Wimberger, HS Rugo, Antoinette R. Tan, C D'Aquanno, Yi Ding, Vassiliki Karantza, Peter Schmid
201822
11
Concomitant chemotherapy and radiotherapy for locally advanced nasopharyngeal carcinoma.
PubMed ·Cheng Sh, Liu Tw, Jian Jj, Tsai Sy, Hao Sp, Chien‐Hua Huang, MC Liu, Yu B, Huang At
199719
12
HIF-1α repairs degenerative chondrocyte glycolytic metabolism by the transcriptional regulation of Runx2.
PubMed ·Pengfei Kong, Ruge Chen, F-Q Zou, Y Wang, MC Liu, W-G Wang
202116
13
Intestinal capillariasis: report of a case.
PubMed ·Chao‐Yu Chen, Hsieh Wc, Lin Jt, MC Liu
198915
14
Abstract P6-18-09: Clinical management of metastatic breast cancer (MBC) after CDK 4/6 inhibitors: A retrospective single-institution study
Cancer Research ·KV Giridhar, Gerald Choong, RA Leon-Ferre, CC O'Sullivan, KJ Ruddy, TC Haddad, TJ Hobday, PP Peethambaram, TJ Moynihan, CL Loprinzi, MC Liu, VJ Suman, MP Goetz
20199
15
Abstract P1-01-01: Circulating tumor cell number and CTC-endocrine therapy index predict clinical outcomes in ER positive metastatic breast cancer patients: Results of the COMETI Phase 2 trial
Cancer Research ·Costanza Paoletti, MM Regan, MC Liu, P. Kelly Marcom, L. Hart, J. Smith, KL Tedesco, Eitan Amir, IE Krop, A. DeMichele, PJ Goodwin, M Block, KoKo Aung, EM Cannell, EP Darga, PJ Baratta, ME Brown, R J McCormack, DF Hayes
20178
16
Five Decades as a Mathematician and Educator
WORLD SCIENTIFIC eBooks ·K-Y Chan, MC Liu
19958
17
Breast-conserving surgery and radiotherapy for early breast cancer.
PubMed ·Cheng Sh, Chuan‐Mu Chen, Jian Jj, Tsai Sy, Liu Wt, MC Liu, (unknown), (unknown)
19968
18
S1-8: Molecular Signaling Distinguishes Early ER Positive Breast Cancer Recurrences Despite Adjuvant Tamoxifen.
Cancer Research ·MC Liu, J. Michael Dixon, JJ Xuan, Rebecca B. Riggins, L Chen, C Wang, Y Cho, Yusong Zhu, Lai Jin, Alan Zwart, M Wang, UM Klimach, Yijie Wang, Lorna Renshaw, Alexey A. Larionov, WR Miller, Robert B. Clarke
20116
19
Abstract PD09-03: Impact of BRCA1/2 Mutation Status in TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple negative breast cancer.
Cancer Research ·SJ Isakoff, PE Goss, EL Mayer, Tiffany A. Traina, LA Carey, KJ Krag, MC Liu, Hope S. Rugo, Vered Stearns, Steven E. Come, Dianne M. Finkelstein, A-R Hartman, J. E. Garber, Patrick J. Ryan, EP Winer, LW Ellisen
20125
20
Abstract P6-21-03: Phase I trial of intratumoral (IT) administration of a NIS-expressing derivative manufactured from a genetically engineered strain of measles virus (MV)
Cancer Research ·MC Liu, K-W Peng, MJ Federspiel, Stewart J. Russell, BA Brunton, Yidong Zhou, Nandakumar Packiriswamy, JM Hubbard, CL Loprinzi, PP Peethambaram, KJ Ruddy, JB Allred, E. Galanis, SH Okuno
20195

About MC Liu

MC Liu is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Hematology, having authored 32 papers that have together received 735 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (6 papers), Acute Myeloid Leukemia Research (6 papers), Breast Cancer Treatment Studies (5 papers), Cancer Treatment and Pharmacology (4 papers), Cancer Genomics and Diagnostics (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), HER2/EGFR in Cancer Research (3 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Hematology (426 citations), Genetics (158 citations), Cancer Research (164 citations), Oncology (167 citations) and Otorhinolaryngology (17 citations). MC Liu has collaborated with scholars based in Taiwan, United States and United Kingdom. Frequent co-authors include Ming Yao, S-J Wu, M-H Tseng, C-Y Chen, C-W Liu, Woei Tsay, Bor‐Sheng Ko, Yee‐Chun Chen, Lee Fy and Liang‐In Lin. Their work appears in journals such as Cancer Research, Leukemia, Blood Cancer Journal, Annals of Oncology and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. BekeleBreakdown of academic impact, for papers by Heinz-A. HorstBreakdown of academic impact, for papers by Prapti A. PatelBreakdown of academic impact, for papers by M VanrumbekeBreakdown of academic impact, for papers by R B ArlinghausBreakdown of academic impact, for papers by Sujiang ZhangBreakdown of academic impact, for papers by M LübbertBreakdown of academic impact, for papers by Vera MagistroniBreakdown of academic impact, for papers by François G. KavelaarsBreakdown of academic impact, for papers by Rhonda E. Ries